» Oxford BioMedicaThe Sputnik Group

Oxford BioMedica

A biopharmaceutical company specialising in the development of novel genebased therapeutics with a focus on the areas of oncology and neurotherapy. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock Exchange. Oxford BioMedica has core expertise in gene delivery, as well as in-house clinical, regulatory and manufacturing know-how.